ABBOTT LABORATORIES — Director's Dealing 2015

Feb 19, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2015-02-06

Reporting Person: Pavee Jean-Yves (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-06	Common shares without par value	G	2966	—	Disposed	24817	Direct
2015-02-15	Common shares without par value	F	1001	$46.09	Disposed	23816	Direct
2015-02-17	Common shares without par value	F	283	$46.09	Disposed	23533	Direct
2015-02-17	Common shares without par value	S	621	$46.411	Disposed	22912	Direct
2015-02-06	Common shares without par value	G	2966	—	Acquired	2966	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	2511	Indirect
Common shares without par value	2967	Indirect
Common shares without par value	2966	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 17, 2015.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter.

F3: The reporting person disclaims beneficial ownership of all securities held by his son.